Abstract
The prevalence of Alzheimer's disease is predicted to reach 13.2 million cases in the United States. This article considers current therapeutic approaches for Alzheimer's disease. Optimal management requires accurate diagnosis, which is increasingly based on an understanding of pathophysiology. Neuroprotective strategies, cholinesterase inhibitors, psychopharmacologic agents that may reduce behavioral disturbances, and newer agents such as memantine are discussed.
Citation impact
1,126
total citations
- FWCI
- 34.89
- Percentile
- 100%
- References
- 79
Citations per year
Authors
1Topics & keywords
Topics
Keywords
- Memantine
- Medicine
- Disease
- Neuroprotection
- Alzheimer's disease
- Cholinesterase
- Rivastigmine
- Intensive care medicine
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.